tirzepatide lawsuit fda Eli Lilly targets approval for weight loss medication The FDA says the Zepbound

Seismic shifts like this create a rare alignment between public health goals and commercial opportunity

According to the NEDC, people experiencing disordered eating may misuse GLP-1 agonists "in an attempt to control their weight or compensate for food intake", which can lead to "dangerous health consequences"

Its your diabetes

The FDA has issued warnings about some compounding pharmacies using "semaglutide sodium" or "semaglutide acetate." These are salt formulations of the drug that are not the same active ingredient used in the brand-name medications

From transient episodes to chronic disorders, the spectrum is broad

Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss